A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector

24 September 2019

The value added medicines sector group of Medicines for Europe […]

Ready to drive access to medicines

21 June 2019

Medicines for Europe is ready to engage with the EU […]

European Specialised Nurses Organisation (ESNO) launches translations into multiple European languages of switch management guide between similar biological medicines, for nurses

20 June 2019

Committing to Global Health: Balancing Access and Sustainability key to success

13 June 2019

Global medicine manufacturers gathered in Warsaw this week to discuss […]

Huge European Parliament majority votes to adopt the SPC manufacturing waiver

17 April 2019

The European Parliament today voted overwhelmingly with 572 Members of […]

‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access

3 April 2019

Medicines for Europe has launched its vision for pharmaceutical policy […]

Accelerating the biosimilar medicines access journey through benefit-sharing

28 March 2019

Biosimilar medicines have significantly increased equity of access to important […]

Major challenges in the Intellectual Property (IP) environment for pharmaceuticals debated at Medicines for Europe Legal Conference

27 March 2019

The SPC manufacturing waiver, which will put an end to […]

Joint Press Statement of the Inter Associations Initiative (IAI) Pharmaceuticals in the Environment Task Force (AESGP, EFPIA, Medicines for Europe) – European Union Strategic Approach to Pharmaceuticals in the Environment

12 March 2019

Report calls for better environment to improve patient access to value added medicines

26 February 2019

A new report launched today lays out clear recommendations to […]